Key Highlights

  • TTMI shares fell about 11.31% Tuesday to $125.04 from a prior close near $141.01, extending a decline that began Monday when the stock dipped roughly 1.7% on deal-related news.
  • The primary catalyst is TTM's August 17 announcement of a definitive agreement to acquire defense-electronics maker Epiq Solutions for approximately $1.1 billion in an all-cash, debt-financed deal, pushing net Leverage to 2.3x at close and reviving investor concerns about integration risk seen after a similar Acquisition announcement in June.
  • Truist raised its price target on TTMI to $224 from $215 while maintaining a Buy rating even as shares fell, and the company's own Q2 2026 results, reported August 5, were record: net sales of $1.0 billion, up 37% year-over-year, with non-GAAP EPS of $0.99.
  • The slide also coincides with a broader profit-taking pullback across semiconductor and AI-supply-chain names following Fabrinet's post-earnings reversal, plus a spike in the 30-year Treasury Yield above 5.3% that raises the cost of debt-funded M&A.

A Debt-Financed Defense Deal Spooks Investors

TTM Technologies announced on August 17 a definitive agreement to acquire Epiq Design Solutions, a maker of software-defined radios and radiation-tolerant computing products for the defense and space markets, for roughly $1.1 billion in cash. The deal is backed by committed financing from JPMorgan, Bank of America, and Barclays, carries a synergy-adjusted multiple of 17.4 times Epiq's expected 2027 adjusted EBITDA, and is expected to be accretive to adjusted EBITDA margins immediately and to non-GAAP EPS in 2028. Net leverage is projected at 2.3x at close, with a target of 1.5x-1.7x within 12-18 months. Shares dipped about 1.7% Monday as the market began digesting the terms, then fell far more sharply Tuesday as leverage and integration-risk concerns intensified.

Echoes Of A Similar June Selloff

This is not the first time a TTM acquisition has triggered investor unease. In June 2026, the company's announced purchase of Swiss Technology Group AG and ILFA GmbH sent shares down about 6.9% as investors questioned whether European Manufacturing expansion justified added leverage after TTM secured a $400 million term Loan and $1.0 billion revolving Credit facility. The Epiq deal follows the same playbook on a larger scale, layering a $1.1 billion debt-financed acquisition onto a Balance Sheet already stretched by prior expansion, at a moment when the 30-year Treasury yield has climbed above 5.3% for the first time since 2007, raising the cost of financing large, leveraged transactions across the market.

Strong Fundamentals, Bullish Analyst Action

The pullback comes despite genuinely strong underlying results. TTM's Q2 2026 report on August 5 showed record net sales of $1.0 billion, up 37% year-over-year, and non-GAAP EPS of $0.99, with full-year 2026 guidance raised to approximately $4.4 billion in net sales and non-GAAP EPS approaching $5.00, excluding any impact from pending European acquisitions. Truist responded to the Epiq announcement by raising its price target to $224 from $215 while maintaining a Buy rating. Today's decline also lines up with a broader semiconductor and AI-infrastructure-supply-chain selloff tied to Fabrinet's post-earnings reversal, suggesting TTM's move reflects both deal-specific leverage concerns and sector-wide risk-off positioning.

Bottom Line

TTM Technologies shares are down sharply over two sessions as investors digest the leverage and integration risk of its $1.1 billion debt-financed Epiq Solutions acquisition, even as the company posted record Q2 2026 results and Truist raised its price target to $224. These are the verified facts as reported. Whether the pullback extends may depend on how quickly TTM can demonstrate a credible path back toward its targeted 1.5x-1.7x leverage range and whether the Epiq deal closes on schedule without regulatory or financing complications.